Providing support from target validation through lead optimization to in vivo proof of concept
The beLAB2122 partners understand the needs and constraints of bringing an early-stage drug discovery project to a value-inflection point where investors would typically like to invest.
Together with the PI, we take a close look at each project and develop a milestone driven work plan that recognizes the expertise of each partner. With success-based financing of each project potentially up to USD 1.5 m, we ensure that we can drive a project to in vivo proof of concept and beyond (amount will be converted to EUR at current exchange rate).
After acceptance of your project following review by a Joint Steering Committee (JSC), the funded work is typically shared between the academic partner and Evotec where a dedicated project leader with drug discovery expertise is assigned to guide each program. In funding the project, we aim to recognize the expertise of the individual partners to ensure the most efficient achievement of the goals and thus transition to the next phase.